Related Experiment Video
Updated: Jan 30, 2026

Measuring Attentional Biases for Threat in Children and Adults
Published on: October 19, 2014
Children Are Not Small Adults, but Can We Treat Them As Such?
Elke H J Krekels1, Elisa A M Calvier1, Piet H van der Graaf1,2
1Division of Systems Biomedicine and Pharmacology, Leiden Academic Center of Drug Research, Leiden University, Leiden, The Netherlands.
Insights
Linear scaling of drug plasma clearance (CLp) is accurate for pediatric patients down to 1 month for glomerular filtration and 2 years for hepatic clearance, suggesting they can often be treated as small adults.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Pediatric Pharmacology
- Physiologically Based Pharmacokinetic (PBPK) Modeling
Background:
- Pediatric drug dosing presents challenges due to nonlinear pharmacokinetic processes in children.
- Current pediatric dosing often relies on weight-based (per kilogram) calculations, assuming children are small adults.
- Allometric scaling (AS 0.75) is a common method for extrapolating adult drug clearance to pediatric populations.
Purpose of the Study:
- To evaluate the accuracy of linear scaling of plasma clearance (CLp) in pediatric patients across different age groups.
- To compare linear scaling with fixed allometric scaling (AS 0.75) for hypothetical drugs with varying parameters.
- To determine the reliability of treating pediatric patients as small adults for drug clearance estimations.
Main Methods:
- A physiologically based pharmacokinetic (PBPK) workflow was employed to model drug clearance.
- Hypothetical drugs with a range of realistic parameter values were simulated in pediatric patients of various ages.
- Linear CLp scaling and fixed allometric scaling (AS 0.75) were compared against PBPK model outputs.
Main Results:
- Linear CLp scaling demonstrated accuracy down to 1 month of age for drugs cleared by glomerular filtration, with exceptions for highly alpha-1-acid glycoprotein (AGP)-bound drugs.
- For hepatically cleared drugs, linear scaling was accurate down to 2 years of age, except for AGP-bound drugs with low extraction ratios and mature isoenzymes.
- In neonates, linear scaling outperformed AS 0.75 for drugs bound to human serum albumin (HSA) and AGP that undergo glomerular filtration.
Conclusions:
- Linear scaling of plasma clearance is a reliable method for pediatric drug dosing in many scenarios.
- The findings support the concept that pediatric patients can be considered small adults for drug clearance estimations in numerous cases.
- Exceptions to linear scaling accuracy highlight the importance of drug-specific properties like protein binding and metabolic pathways.
Abstract:
Although children cannot be considered small adults due to nonlinear processes underlying the pharmacokinetics of drugs, pediatric doses are typically still expressed per kilogram. We use a physiologically based pharmacokinetic (PBPK) workflow to assess the accuracy of linear scaling of plasma clearance (CLp) for hypothetical drugs with ranges of realistic parameter values in pediatric patients of different ages. The results are compared with 0.75 fixed allometric scaling (AS 0.75). Linear CLp scaling is accurate down to the age of 1 month for drugs undergoing glomerular filtration, except when these drugs are highly bound to alpha-1-acid glycoprotein (AGP). For hepatically cleared drugs, linear scaling is reasonably accurate down the age of 2 years, except for AGP-bound drugs with a low extraction ratio and mature isoenzymes. In neonates, linear scaling outperforms AS 0.75 for human serum albumin (HSA) and AGP-bound drugs excreted through glomerular filtration. These results suggest that pediatric patients can, in many cases, be treated as small adults.
Related Concept Videos
Drug Dosing: Infants and Children
Adult Stem Cells
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Cardiopulmonary Resuscitation I: Adult
Relationship with Other Adult Family Members and Siblings
Revisionist Views of Adolescent and Adult Cognition

